Chronic myeloid leukemia patient manifesting fatal hepatitis B virus reactivation during treatment with imatinib rescued by liver transplantation: Case report and literature review

International Journal of Hematology

Volumn 90, Issue 3, 2009, Pages 383-387

  Kang, Byung Woog ^a   Lee, Soo Jung ^a   Moon, Joon Ho ^a   Kim, Shi Nae ^a   Chae, Yee Soo ^a   Kim, Jong Gwang ^a   Hwang, Yoon Jin ^a   Sohn, Sang Kyun ^a  

^a Kyungpook National University Hospital   (South Korea)

Author keywords

Chronic myeloid leukemia; Hepatitis B virus; Imatinib mesylate; Liver transplantation; Reactivation

Indexed keywords

ALANINE AMINOTRANSFERASE; BILIRUBIN; HYDROXYUREA; IMATINIB; LAMIVUDINE; TACROLIMUS;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BILIRUBIN BLOOD LEVEL; CASE REPORT; CHRONIC MYELOID LEUKEMIA; DRUG DOSE REDUCTION; HEPATITIS B; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER TRANSPLANTATION; MALE; SIDE EFFECT; VIRUS REACTIVATION;

ANTINEOPLASTIC AGENTS; HEPATITIS B, CHRONIC; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PIPERAZINES; PYRIMIDINES; REMISSION INDUCTION; SEVERITY OF ILLNESS INDEX;

EID: 76449112173     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12185-009-0386-2     Document Type: Article

References (23)

1. G Lalazar D Rund D Shouval 2007 Screening, prevention and treatment of viral hepatitis B reactivation in patients with haematological malignancies Br J Haematol 136 699 712 10.1111/j.1365-2141.2006.06465.x 1:CAS:528: DC%2BD2sXjvFWmtb0%3D 17338776 (Pubitemid 46246304)
2. R Liang 2009 How I treat and monitor viral hepatitis B infection in patients receiving intensive immunosuppressive therapies or undergoing hematopoietic stem cell transplantation Blood 113 3147 3153 10.1182/blood-2008- 10-163493 1:CAS:528:DC%2BD1MXksFWqsLw%3D 19144986
3. JM Daniels A Vonk-Noordegraaf JJ Janssen PE Postmus AR van 2009 Tuberculosis complicating imatinib treatment for chronic myeloid leukaemia Eur Respir J 33 670 672 10.1183/09031936.00025408 1:CAS:528:DC%2BD1MXktFCgur4%3D 19251803
4. K Cwynarski R Laylor E Macchiarulo J Goldman G Lombardi JV Melo, et al. 2004 Imatinib inhibits the activation and proliferation of normal T lymphocytes in vitro Leukemia 18 1332 1339 10.1038/sj.leu.2403401 1:CAS:528: DC%2BD2cXlvVehsr0%3D 15190258 (Pubitemid 39136740)
5. W Yeo B Zee S Zhong PK Chan WL Wong WM Ho, et al. 2004 Comprehensive analysis of risk factors associating with Hepatitis B virus (HBV) reactivation in cancer patients undergoing cytotoxic chemotherapy Br J Cancer 90 1306 1311 10.1038/sj.bjc.6601699 1:CAS:528:DC%2BD2cXis1aitL0%3D 15054446 (Pubitemid 38586252)
6. S Gupta S Govindarajan TL Fong AG Redeker 1990 Spontaneous reactivation in chronic hepatitis B: patterns and natural history J Clin Gastroenterol 12 562 568 10.1097/00004836-199010000-00015 1:STN:280:DyaK3M%2Fjs1OqtQ%3D%3D 2230000
7. MH Cohen G Williams JR Johnson J Duan J Gobburu A Rahman, et al. 2002 Approval summary for imatinib mesylate capsules in the treatment of chronic myelogenous leukemia Clin Cancer Res 8 935 942 1:CAS:528:DC%2BD38XksVSqtbs%3D 12006504
8. BJ Druker M Talpaz DJ Resta B Peng E Buchdunger JM Ford, et al. 2001 Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia N Engl J Med 344 1031 1037 10.1056/NEJM200104053441401 1:CAS:528:DC%2BD3MXivFGnu70%3D 11287972 (Pubitemid 32267972)
9. K Ikeda Y Shiga A Takahashi T Kai H Kimura K Takeyama, et al. 2006 Fatal hepatitis B virus reactivation in a chronic myeloid leukemia patient during imatinib mesylate treatment Leuk Lymphoma 47 155 157 10.1080/14639230500236818 1:CAS:528:DC%2BD2MXht1Kntb%2FF 16321842 (Pubitemid 43101740)
10. TJ Thia HH Tan TH Chuah WC Chow HF Lui 2008 Imatinib mesylate-related fatal acute hepatic failure in a patient with chronic myeloid leukaemia and chronic hepatitis B infection Singapore Med J 49 e86 e89 1:STN:280: DC%2BD1c3gsVCgug%3D%3D 18362995
11. YF Liaw 1998 Hepatitis viruses under immunosuppressive agents J Gastroenterol Hepatol 13 14 20 10.1111/j.1440-1746.1998.tb00539.x 1:CAS:528:DyaK1cXisVWktbw%3D 9737566
12. S Appel S Balabanov TH Brummendorf P Brossart 2005 Effects of imatinib on normal hematopoiesis and immune activation Stem Cells 23 1082 1088 10.1634/stemcells.2005-0069 1:CAS:528:DC%2BD2MXhtFCks7rE 16140870 (Pubitemid 41377724)
13. J Chen A Schmitt K Giannopoulos B Chen M Rojewski H Dohner, et al. 2007 Imatinib impairs the proliferation and function of CD4+CD25+ regulatory T cells in a dose-dependent manner Int J Oncol 31 1133 1139 1:CAS:528:DC%2BD2sXhtlKhsrfK 17912440
14. N Larmonier N Janikashvili CJ LaCasse CB Larmonier J Cantrell E Situ, et al. 2008 Imatinib mesylate inhibits CD4+ CD25+ regulatory T cell activity and enhances active immunotherapy against BCR-ABL- tumors J Immunol 181 6955 6963 1:CAS:528:DC%2BD1cXhtlaisr3K 18981115
15. S Appel AM Boehmler F Grunebach MR Muller A Rupf MM Weck, et al. 2004 Imatinib mesylate affects the development and function of dendritic cells generated from CD34+ peripheral blood progenitor cells Blood 103 538 544 10.1182/blood-2003-03-0975 1:CAS:528:DC%2BD2cXmsFCisg%3D%3D 14504105 (Pubitemid 38140084)
16. AB Dietz L Souan GJ Knutson PA Bulur MR Litzow S Vuk-Pavlovic 2004 Imatinib mesylate inhibits T-cell proliferation in vitro and delayed-type hypersensitivity in vivo Blood 104 1094 1099 10.1182/blood-2003-12-4266 1:CAS:528:DC%2BD2cXmslKgsLo%3D 15100154 (Pubitemid 39038030)
17. GN Mattiuzzi JE Cortes M Talpaz J Reuben MB Rios J Shan, et al. 2003 Development of Varicella-Zoster virus infection in patients with chronic myelogenous leukemia treated with imatinib mesylate Clin Cancer Res 9 976 980 1:CAS:528:DC%2BD3sXhvFKiu74%3D 12631595 (Pubitemid 36323700)
18. M Speletas TA Vyzantiadis F Kalala D Plastiras K Kokoviadou A Antoniadis, et al. 2008 Pneumonia caused by Candida krusei and Candida glabrata in a patient with chronic myeloid leukemia receiving imatinib mesylate treatment Med Mycol 46 259 263 10.1080/13693780701558969 1:CAS:528:DC%2BD1cXksFarur0%3D 17885950
19. D Gotthardt C Riediger KH Weiss J Encke P Schemmer J Schmidt, et al. 2007 Fulminant hepatic failure: etiology and indications for liver transplantation Nephrol Dial Transplant 22 Suppl 8 viii5 viii8 10.1093/ndt/gfm650 17890263
20. IW Liou AM Larson 2008 Role of liver transplantation in acute liver failure Semin Liver Dis 28 201 209 10.1055/s-2008-1073119 18452119 (Pubitemid 351632959)
21. H Yeh KM Olthoff 2008 Live donor adult liver transplantation Curr Opin Organ Transplant 13 241 246 10.1097/MOT.0b013e328300a352 18685310
22. R Reding 2005 Is it right to promote living donor liver transplantation for fulminant hepatic failure in pediatric recipients? Am J Transplant 5 1587 1591 10.1111/j.1600-6143.2005.00915.x 15943615 (Pubitemid 40910440)
23. M Shimada M Fujii Y Morine S Imura T Ikemoto H Ishibashi 2005 Living-donor liver transplantation: present status and future perspective J Med Invest 52 22 32 10.2152/jmi.52.22 15751270 (Pubitemid 40514413)